Clinical and Radiologic Features of Pedicatric Opioid Use-Associated Neurotoxicity with Cerebellar Edema (POUNCE) Syndrome
Neurol 94:710-712, Kim, D.D. & Prasad, A.N., 2020
Lithium-Induced Reversible Pisa Syndrome
Neurol 88:e184, Kumar, N.,et al, 2017
Dystonia in Children and Adolescents: A Systematic Review and a New Diagnostic Algorithm
JNNP 86:774-781, Van Egmond, M.E.,et al, 2015
Withdrawing Amantadine in Dyskinetic Patients with Parkinson Disease
Neurol 82:300-307, Ory-Magne, F.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Antipsychosis Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1208, Ropper, A.H.,et al, 2014
High Doses of Deferiprone May Be Associated with Cerebellar Syndrome
BMJ 338:653, Beau-Salinas,F.,et al, 2009
Cetirizine-Induced Dystonic Movements
Neurol 66:143-144, Rajput,A. &Baerg,K., 2006
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Ptosis as a Remote Effect of Therapeutic Botulinum Toxin B Injection
Neurol 59:1445-1447, Racette,B.A.,et al, 2002
Drug-Induced Pisa Syndrome (Pleurothotomus)
CNS Drugs 10:166-174, Suzuki, T. & Matsuzaka, H., 2002
Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000
Acute Dystonia Induced by Drug Treatment
BMJ 319:623-626, vanHarten,P.N.,et al, 1999
Tardive Dyskinesia:Diagnosis, Pathogenesis, and Management
The Neurologist 4:180-187, Trugman,J.M., 1998
Dystonia and Chorea in Acquired Systemic Disorders
JNNP 65:436-445, Janavs,J.L.&Aminoff,M.J., 1998
Movement Disorders Associated with the Serotonin Selective Reuptake Inhibitors
J Clin Psychiatry 57:449-454, Leo,R.J., 1996
Involuntary Movement Disorders Associated with Felbamate
Neurol 45:185-187, Kerrick,J.M.,et al, 1995
Pain and Remote Weakness in Limbs Injected with Botulinum Toxin A for Writer's Cramp
Lancet 346:154-156, Sheean,G.L.,et al, 1995
Botulinum Toxin Therapy for Limb Dystonias
Neurol 42:627-630, Yoshimura,D.M.,et al, 1992
Dysphagia After Botulinum Toxin Injections for Spasmodic Torticolli:Clinical and Radiologic Findings
Neurol 42:1307-1310, Comella,C.L.,et al, 1992
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Clinical Correlates of Response to Botulinum Toxin Injections
Arch Neurol 48:1253-1256, Jankovic,J.&Schwartz,K.S., 1991
Botulinum Toxin Injections for Cervical Dystonia
Neurol 40:277-280, Jankovic,J.&Schwartz,P.A., 1990
Muscle Cramps
Arch Int Med 150:511-518, McGee,S.R., 1990
Botulinum Toxin Treatment in Spasmodic Torticollis
JNNP 53:640-643, Blacke,J.D.&Lees,A.J., 1990
Persistent Dystonia Associated with Buspirone
Neurol 40:1904, Boylan,K., 1990
Diphenhydramine-Induced Dystonia
Clin Pharmacy 8:471, Santora,J.,et al, 1989
Life-Threatening Cranial Dystonia Following Trihexyphenidyl Withdrawal
Movement Disorders 4:349-353, Gimenez-Roldan,S.,et al, 1989
The Neuroleptic Malignant Syndrome:Agent and Host Interaction
Acta Psychiatr Scand 73:337-347, Shaley,A.&Munitz,H., 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Tardive Dystonia:Late-onset & Persistent Dystonia Caused by Antipsychotic Drugs
Neurol 32:1335-1346, Burke,R.E.,et al, 1982
Acute Dystonia, An Unusual Reaction to Diphenhydramine
JAMA 236:291, Lavenstein,B.L.&Cantor,F.K., 1976